Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_assertion type Assertion NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_head.
- NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_assertion description "[A variety of drug-resistant human cancer cell lines derived by selection with mitoxantrone markedly overexpressed BCRP mRNA; these cell lines included sublines of human breast carcinoma (MCF-7), colon carcinoma (S1 and HT29), gastric carcinoma (EPG85-257), fibrosarcoma (EPF86-079), and myeloma (8226) origins.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_provenance.
- NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_assertion evidence source_evidence_literature NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_provenance.
- NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_assertion SIO_000772 10070941 NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_provenance.
- NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_assertion wasDerivedFrom befree-20140225 NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_provenance.
- NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_assertion wasGeneratedBy ECO_0000203 NP882377.RAllqu4Na8HrJHzO1f2mkO9o7UNCyY6VvVVoMFVnf1SdE130_provenance.